Literature DB >> 2197961

Pharmacokinetics of TGF beta with emphasis on effects in liver and gut.

R J Coffey1, W E Russell, J A Barnard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2197961     DOI： 10.1111/j.1749-6632.1990.tb16120.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Controlled delivery of transforming growth factor β1 by self-assembling peptide hydrogels induces chondrogenesis of bone marrow stromal cells and modulates Smad2/3 signaling.

Authors:  Paul W Kopesky; Eric J Vanderploeg; John D Kisiday; David D Frisbie; John D Sandy; Alan J Grodzinsky
Journal:  Tissue Eng Part A       Date:  2010-09-22       Impact factor: 3.845

2.  Mathematical modeling of fracture healing in mice: comparison between experimental data and numerical simulation results.

Authors:  Liesbet Geris; Alf Gerisch; Christa Maes; Geert Carmeliet; Rüdiger Weiner; Jos Vander Sloten; Hans Van Oosterwyck
Journal:  Med Biol Eng Comput       Date:  2006-03-22       Impact factor: 2.602

3.  Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.

Authors:  S L MacKay; T Auffenberg; C L Tannahill; R Ksontini; M D Josephs; M Nowak; L L Moldawer; E M Copeland
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

4.  Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.

Authors:  S L MacKay; L R Yaswen; R W Tarnuzzer; L L Moldawer; K I Bland; E M Copeland; G S Schultz
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.